Clinical Trial Update: Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at Washington University evaluates reduced-intensity conditioning and familial HLA-mismatched bone marrow transplantation for non-mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure Syndromes
• Hemoglobinopathies
• Immunologic Disorders
• Metabolic Disorders
• Sickle Cell Disease

Snippet

Sponsor: Washington University School of Medicine | Conditions: Severe Sickle Cell Disease, Bone Marrow Failure Syndromes | Phase 1, Phase 2 | Status: RECRUITING